Beijing Tong Ren Tang Chinese Medicine Company Limited
BJTRF
$0.5645
-$0.7413-56.77%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 206.62M | 191.28M | 176.06M | 185.40M | 194.77M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 206.62M | 191.28M | 176.06M | 185.40M | 194.77M |
| Cost of Revenue | 70.05M | 59.60M | 49.20M | 55.09M | 61.00M |
| Gross Profit | 136.57M | 131.68M | 126.86M | 130.31M | 133.77M |
| SG&A Expenses | 63.33M | 60.31M | 57.34M | 56.23M | 55.13M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -341.50K | -753.00K | -1.16M | -1.10M | -1.04M |
| Total Operating Expenses | 133.04M | 119.16M | 105.37M | 110.22M | 115.08M |
| Operating Income | 73.59M | 72.12M | 70.69M | 75.18M | 79.69M |
| Income Before Tax | 80.73M | 79.83M | 78.97M | 83.40M | 87.85M |
| Income Tax Expenses | 12.90M | 11.84M | 10.79M | 11.60M | 12.41M |
| Earnings from Continuing Operations | 67.83 | 67.98 | 68.17 | 71.80 | 75.44 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -3.70M | -4.34M | -4.98M | -5.69M | -6.41M |
| Net Income | 64.13M | 63.65M | 63.20M | 66.11M | 69.03M |
| EBIT | 73.59M | 72.12M | 70.69M | 75.18M | 79.69M |
| EBITDA | 76.00M | 74.41M | 72.86M | 77.33M | 81.82M |
| EPS Basic | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 |
| Normalized Basic EPS | 0.06 | 0.05 | 0.05 | 0.06 | 0.06 |
| EPS Diluted | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 |
| Normalized Diluted EPS | 0.06 | 0.05 | 0.05 | 0.06 | 0.06 |
| Average Basic Shares Outstanding | 3.35B | 3.35B | 3.35B | 3.35B | 3.35B |
| Average Diluted Shares Outstanding | 3.35B | 3.35B | 3.35B | 3.35B | 3.35B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 55.09% | 55.51% | 55.91% | 53.37% | 51.06% |